JP2009501001A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009501001A5 JP2009501001A5 JP2008514849A JP2008514849A JP2009501001A5 JP 2009501001 A5 JP2009501001 A5 JP 2009501001A5 JP 2008514849 A JP2008514849 A JP 2008514849A JP 2008514849 A JP2008514849 A JP 2008514849A JP 2009501001 A5 JP2009501001 A5 JP 2009501001A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- capsid fusion
- fusion peptide
- particle
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 64
- 210000000234 capsid Anatomy 0.000 claims 43
- 230000004927 fusion Effects 0.000 claims 42
- 230000003612 virological effect Effects 0.000 claims 30
- 239000002245 particle Substances 0.000 claims 28
- 230000000890 antigenic effect Effects 0.000 claims 22
- 241000700605 Viruses Species 0.000 claims 18
- 238000000034 method Methods 0.000 claims 16
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 238000000338 in vitro Methods 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 230000002458 infectious effect Effects 0.000 claims 5
- 108091034117 Oligonucleotide Proteins 0.000 claims 4
- 230000003308 immunostimulating effect Effects 0.000 claims 4
- 241000724254 Cowpea chlorotic mottle virus Species 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000001717 pathogenic effect Effects 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 241000589540 Pseudomonas fluorescens Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000000593 degrading effect Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68654105P | 2005-06-01 | 2005-06-01 | |
| PCT/US2006/021262 WO2007053188A2 (en) | 2005-06-01 | 2006-06-01 | Production of multivalent virus like particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009501001A JP2009501001A (ja) | 2009-01-15 |
| JP2009501001A5 true JP2009501001A5 (https=) | 2009-07-09 |
Family
ID=38006346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514849A Pending JP2009501001A (ja) | 2005-06-01 | 2006-06-01 | 多価ウイルス様粒子の製造 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070041999A1 (https=) |
| EP (1) | EP1885394A4 (https=) |
| JP (1) | JP2009501001A (https=) |
| KR (1) | KR20080018176A (https=) |
| CN (1) | CN101287489A (https=) |
| AU (1) | AU2006309286A1 (https=) |
| BR (1) | BRPI0611336A2 (https=) |
| CA (1) | CA2608515A1 (https=) |
| WO (1) | WO2007053188A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100021391A1 (en) * | 2006-07-14 | 2010-01-28 | Montana State University | Novel nanoparticles for biofilm targeting |
| SG10202012986SA (en) | 2006-09-29 | 2021-01-28 | Ligocyte Pharmaceuticals Inc | Norovirus vaccine formulations |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| JP2010539192A (ja) | 2007-09-18 | 2010-12-16 | リゴサイト ファーマスーティカルズ，インコーポレイテッド | ノロウイルスに対して防御免疫応答を付与する方法 |
| US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| US9566323B2 (en) * | 2009-06-19 | 2017-02-14 | Eyegene Inc. | Vaccine for cervical cancer |
| AU2011276328C1 (en) | 2010-07-06 | 2016-01-21 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
| CA2841356C (en) | 2011-07-11 | 2022-03-01 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| CA2872803C (en) * | 2012-05-11 | 2016-10-11 | Medicago Inc. | Rotavirus-like particle production in plants |
| EP2870238A4 (en) | 2012-07-05 | 2016-03-09 | Ohio State Innovation Foundation | COMPOSITIONS AND METHODS RELATED TO VIRAL VACCINES |
| US10086062B2 (en) | 2012-07-05 | 2018-10-02 | Ohio State Innovation Foundation | Infectious pancreatic necrosis virus (IPNV) vaccine compositions |
| WO2015101666A1 (en) * | 2014-01-03 | 2015-07-09 | Fundación Biofísica Bizkaia | VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF |
| WO2015191546A2 (en) * | 2014-06-10 | 2015-12-17 | The Board Of Regents Of The University Of Texas System | Adp-ribose detection reagents |
| CN105018463A (zh) * | 2015-06-05 | 2015-11-04 | 北京百迈客生物科技有限公司 | 一种用于次生代谢物含量高的植物组织的dna提取方法 |
| KR101830792B1 (ko) * | 2016-01-27 | 2018-02-21 | 건국대학교 산학협력단 | 항균 펩타이드를 포함하는 불용성 융합단백질 및 이를 이용한 항균 펩타이드의 제조 방법 |
| CN108558990A (zh) * | 2018-01-05 | 2018-09-21 | 山东省科学院生态研究所 | 肿瘤靶向肽f3修饰的豇豆褪绿斑驳病毒样颗粒的构建、表达及其应用 |
| US20230038487A1 (en) * | 2019-11-25 | 2023-02-09 | The Regents Of The University Of California | Modified viral therapeutics and uses thereof |
| US12440553B2 (en) | 2020-11-11 | 2025-10-14 | California Institute Of Technology | Multivalent carriers and related vaccine compositions |
| CN115747170B (zh) * | 2022-08-29 | 2023-08-04 | 四川大学 | 一种豇豆褪绿斑驳病毒-多肽复合物及其在骨质疏松治疗中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| GB9108386D0 (en) | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
| GB9414118D0 (en) * | 1994-07-13 | 1994-08-31 | Axis Genetics Ltd | Modified plant viruses as vectors of heterologous peptides |
| US6042832A (en) * | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
| ES2572628T3 (es) * | 1997-09-05 | 2016-06-01 | Medimmune, Inc. | Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP) |
| US6171591B1 (en) | 1997-12-08 | 2001-01-09 | Pentamer Pharmaceuticals, Inc. | Recombinant nodavirus compositions and methods |
| KR100312456B1 (ko) * | 1999-03-13 | 2001-11-03 | 윤덕용 | 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자 |
| US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
| GB9924352D0 (en) * | 1999-10-14 | 1999-12-15 | Hellendoorn Koen | Methods,compositions and applications relating to the generation of novel plant viral particles |
| US7135282B1 (en) * | 1999-10-14 | 2006-11-14 | The Dow Chemical Company | Viral particles with exogenous internal epitopes |
| EP1253947A4 (en) * | 2000-01-31 | 2005-01-05 | Univ California | IMMUNOMODULATORY POLYNUCLEOTIDES FOR THE TREATMENT OF INFECTION BY AN INTRACELLULAR PATHOGEN |
| US20030050268A1 (en) * | 2001-03-29 | 2003-03-13 | Krieg Arthur M. | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases |
| WO2003068163A2 (en) * | 2002-02-14 | 2003-08-21 | Novavax, Inc. | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| US20030235818A1 (en) * | 2002-04-08 | 2003-12-25 | Vsevolod Katritch | Immunogenic peptides, and method of identifying same |
| WO2003103605A2 (en) * | 2002-06-07 | 2003-12-18 | Large Scale Biology Corporation | Flexible vaccine assembly and vaccine delivery platform |
| JP4953570B2 (ja) * | 2002-07-05 | 2012-06-13 | フォリア バイオテック インコーポレイテッド | アジュバントウィルス粒子 |
| WO2005005614A2 (en) | 2003-07-03 | 2005-01-20 | Pecos Labs, Inc. | Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| EP1644034B1 (en) * | 2003-07-10 | 2011-01-12 | Cytos Biotechnology AG | Composition for enhancing an immune response comprising packaged virus-like particles |
| EP1758925A4 (en) * | 2003-12-01 | 2009-04-08 | Dow Global Technologies Inc | PRODUCTION OF A RECOMBINANT ICOSAHEDRIC VIRUS LIKE PARTICLE |
-
2006
- 2006-06-01 WO PCT/US2006/021262 patent/WO2007053188A2/en not_active Ceased
- 2006-06-01 BR BRPI0611336-2A patent/BRPI0611336A2/pt not_active IP Right Cessation
- 2006-06-01 AU AU2006309286A patent/AU2006309286A1/en not_active Abandoned
- 2006-06-01 JP JP2008514849A patent/JP2009501001A/ja active Pending
- 2006-06-01 KR KR1020077028015A patent/KR20080018176A/ko not_active Withdrawn
- 2006-06-01 CN CNA2006800196237A patent/CN101287489A/zh active Pending
- 2006-06-01 CA CA002608515A patent/CA2608515A1/en not_active Abandoned
- 2006-06-01 EP EP06844120A patent/EP1885394A4/en not_active Withdrawn
- 2006-06-01 US US11/444,827 patent/US20070041999A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009501001A5 (https=) | ||
| Kanekiyo et al. | New vaccine design and delivery technologies | |
| TWI688652B (zh) | 作為對抗腸病毒感染之免疫原的病毒顆粒及其製造 | |
| Yan et al. | The application of virus-like particles as vaccines and biological vehicles | |
| Pushko et al. | Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures | |
| Naskalska et al. | Virus like particles as immunogens and universal nanocarriers | |
| JP2002541854A5 (https=) | ||
| Sarkar et al. | Virus like particles-A recent advancement in vaccine development | |
| WO2005055957A3 (en) | Influenza immunogen and vaccine | |
| Betenbaugh et al. | Nucleocapsid-and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus | |
| WO2000032227A3 (en) | Ordered molecular presentation of antigens, method of preparation and use | |
| CA2405438A1 (en) | Hepatitis b core antigen fusion proteins | |
| JP2007512842A5 (https=) | ||
| WO2007019247A3 (en) | Virus-like particles as vaccines for paramyxovirus | |
| JP2004500842A5 (https=) | ||
| JP2017515508A5 (https=) | ||
| JP2006504644A5 (https=) | ||
| WO2009014782A3 (en) | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles | |
| CN104611358B (zh) | 一种在大肠杆菌中制备诺如病毒病毒样颗粒的方法 | |
| JP2025169275A5 (https=) | ||
| CN108456663A (zh) | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 | |
| Jeoung et al. | Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig | |
| JPWO2020139978A5 (https=) | ||
| JP2003514576A5 (https=) | ||
| JP2009501012A5 (https=) |